HUTCHMED (China) Limited (AIM:HCM)
London · Delayed Price · Currency is GBP · Price in GBX 201.62
-0.39 (-0.19%)
Jan 6, 2026, 11:53 AM GMT
HUTCHMED (China) Market Cap
HUTCHMED (China) has a market cap or net worth of 1.74 billion as of January 6, 2026. Its market cap has decreased by -14.66% in one year.
Market Cap
1.74B
Enterprise Value
822.03M
Revenue
439.54M
Ranking
n/a
PE Ratio
5.22
Stock Price
201.62
Market Cap Chart
Since May 19, 2006, HUTCHMED (China)'s market cap has increased from 128.29M to 1.74B, an increase of 1,253.15%. That is a compound annual growth rate of 14.18%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 5, 2026 | 1.74B | -2.88% |
| Dec 31, 2025 | 1.79B | -11.00% |
| Dec 31, 2024 | 2.01B | -16.84% |
| Dec 29, 2023 | 2.42B | 8.25% |
| Dec 30, 2022 | 2.23B | -50.85% |
| Dec 31, 2021 | 4.54B | 36.26% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 207.55B |
| GSK plc | 73.04B |
| Haleon | 33.16B |
| Smith & Nephew | 10.43B |
| Convatec Group | 4.69B |
| Hikma Pharmaceuticals | 3.38B |
| Genus | 1.69B |
| Oxford Nanopore Technologies | 1.26B |